The US FDA has designated a recall from Teleflex subsidiary Arrow International class I, its most serious level.
The company recalled 16, 959 intra-aortic balloon (IAB) catheter kits distributed in the US from May 2022 through April 2024.
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?